스마트 감염 예방 시스템 시장 : 시장 분석 및 예측 - 유형별, 제품별, 서비스별, 기술별, 컴포넌트별, 용도별, 전개별, 최종 사용자별, 기능별(-2035년)

The global Smart Infection Prevention Systems Market is projected to grow from $245.2 billion in 2025 to $496.0 billion by 2035, at a compound annual growth rate (CAGR) of 7.3%. The Smart Infection Prevention Systems Market is driven by the need for automated infection surveillance, environmental monitoring, and improved hospital cleaning. In September 2025, the CDC released resources encouraging hospitals to optimize and objectively monitor high-touch surface cleaning during patient discharge or transfer. In December 2025, the U.S. FDA addressed emerging germicidal ultraviolet technologies designed to reduce microbial loads on healthcare surfaces as an adjunct to routine cleaning and disinfection. Advances in UV disinfection, smart sensors, automated cleaning verification, antimicrobial surfaces, and infection surveillance software are strengthening hospital infection-control workflows.

The Type segment of the Smart Infection Prevention Systems Market includes Automated Systems, Manual Systems, Hybrid Systems, and Others. Automated Systems dominated the market in 2025 due to their ability to continuously monitor hygiene conditions, automate disinfection processes, reduce human error, and improve infection-control efficiency. Increasing adoption of UV-C devices, automated sterilization equipment, sensors, robotics, and AI-enabled monitoring is further supporting demand. Hybrid Systems are expected to be the fastest-growing segment during the forecast period, driven by their ability to combine automated technologies with manual infection-control procedures. Their flexibility, improved operational reliability, and suitability for healthcare facilities with existing infection-prevention infrastructure are expected to encourage broader adoption.

The Application segment of the Smart Infection Prevention Systems Market includes Hospitals, Clinics, Laboratories, Pharmaceutical Manufacturing, Food Processing, and Others. Hospitals dominated the market in 2025 due to the high risk of healthcare-associated infections and the need for continuous environmental disinfection, sterilization, and hygiene monitoring. Pharmaceutical Manufacturing is expected to be the fastest-growing segment during the forecast period, supported by stringent contamination-control requirements, increasing pharmaceutical production, and growing adoption of automated sterilization, air purification, sensor-based monitoring, and smart infection-control technologies. The need to maintain controlled manufacturing environments and minimize microbial contamination is expected to drive investment in advanced infection-prevention systems across pharmaceutical production facilities.

Geographical Overview

North America was the leading region in the Smart Infection Prevention Systems Market in 2025, supported by advanced healthcare infrastructure, stringent infection-control requirements, and widespread adoption of automated and digital healthcare technologies. Hospitals and healthcare facilities across the United States and Canada increasingly utilize real-time infection surveillance, automated disinfection, digital hygiene monitoring, smart sensors, and data-driven infection-control platforms. The region also benefits from strong healthcare spending, established infection-prevention programs, and the presence of technology providers developing connected solutions for contamination monitoring and hospital hygiene. Growing concerns regarding healthcare-associated infections and antimicrobial resistance further support demand for smart infection prevention systems.

Asia-Pacific is expected to be the fastest-growing region in the Smart Infection Prevention Systems Market during the forecast period, driven by expanding healthcare infrastructure, increasing hospital capacity, rising awareness of healthcare-associated infections, and growing adoption of digital and automated infection-control technologies. China, India, Japan, South Korea, and Southeast Asian countries are expected to contribute significantly as healthcare facilities invest in smart surveillance, automated sterilization, robotic disinfection, connected monitoring systems, and digital hygiene-management platforms. Government initiatives to improve hospital safety and infection-control standards, combined with increasing healthcare expenditure and the expansion of modern hospitals, are expected to accelerate adoption of smart infection prevention solutions across the region.

Key Trends and Drivers

Real-Time Environmental Infection Surveillance:

A key trend in the Smart Infection Prevention Systems market is the move toward continuous, real-time surveillance of hospital environments and infection-control activities. Newer systems monitor factors such as air quality, room conditions, hand-hygiene compliance, patient and equipment movement, and environmental disinfection status, allowing infection risks to be identified as they emerge rather than through periodic manual audits. Intelligent hospital systems can also generate risk rankings and automatically initiate targeted disinfection when abnormal conditions are detected. This shift is making infection prevention more continuous, measurable, and responsive across high-risk healthcare environments.

Rising Burden of Healthcare-Associated Infections:

A major driver of the Smart Infection Prevention Systems market is the persistent burden of healthcare-associated infections (HAIs) and antimicrobial resistance. Hospitals face substantial pressure to prevent infections such as bloodstream infections, urinary tract infections, surgical-site infections, and Clostridioides difficile infections while maintaining high-quality patient care. Manual surveillance requires significant time from infection-prevention personnel, creating demand for automated systems that can identify risks and reduce repetitive monitoring activities. Increasing regulatory reporting requirements and financial consequences associated with poor HAI performance are further encouraging hospitals to adopt digital infection-control technologies capable of improving surveillance, documentation, and preventive interventions.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by Deployment
• 2.8 Key Market Highlights by End User
• 2.9 Key Market Highlights by Functionality

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Automated Systems
  • 4.1.2 Manual Systems
  • 4.1.3 Hybrid Systems
  • 4.1.4 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Disinfectants
  • 4.2.2 Sterilization Equipment
  • 4.2.3 Air Purification Systems
  • 4.2.4 UV-C Devices
  • 4.2.5 Antimicrobial Coatings
  • 4.2.6 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Installation Services
  • 4.3.2 Maintenance Services
  • 4.3.3 Consulting Services
  • 4.3.4 Training Services
  • 4.3.5 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Ultraviolet Technology
  • 4.4.2 Nanotechnology
  • 4.4.3 Sensor Technology
  • 4.4.4 Robotics
  • 4.4.5 AI and Machine Learning
  • 4.4.6 Others
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Sensors
  • 4.5.2 Software
  • 4.5.3 Control Systems
  • 4.5.4 Display Units
  • 4.5.5 Others
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Hospitals
  • 4.6.2 Clinics
  • 4.6.3 Laboratories
  • 4.6.4 Pharmaceutical Manufacturing
  • 4.6.5 Food Processing
  • 4.6.6 Others
• 4.7 Market Size & Forecast by Deployment (2020-2035)
  • 4.7.1 On-Premise
  • 4.7.2 Cloud-Based
  • 4.7.3 Hybrid
  • 4.7.4 Others
• 4.8 Market Size & Forecast by End User (2020-2035)
  • 4.8.1 Healthcare Providers
  • 4.8.2 Pharmaceutical Companies
  • 4.8.3 Food and Beverage Industry
  • 4.8.4 Research Institutes
  • 4.8.5 Others
• 4.9 Market Size & Forecast by Functionality (2020-2035)
  • 4.9.1 Real-Time Monitoring
  • 4.9.2 Automated Reporting
  • 4.9.3 Predictive Analytics
  • 4.9.4 Remote Management
  • 4.9.5 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 Deployment
    • 5.2.1.8 End User
    • 5.2.1.9 Functionality
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 Deployment
    • 5.2.2.8 End User
    • 5.2.2.9 Functionality
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 Deployment
    • 5.2.3.8 End User
    • 5.2.3.9 Functionality
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 Deployment
    • 5.3.1.8 End User
    • 5.3.1.9 Functionality
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 Deployment
    • 5.3.2.8 End User
    • 5.3.2.9 Functionality
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 Deployment
    • 5.3.3.8 End User
    • 5.3.3.9 Functionality
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 Deployment
    • 5.4.1.8 End User
    • 5.4.1.9 Functionality
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 Deployment
    • 5.4.2.8 End User
    • 5.4.2.9 Functionality
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 Deployment
    • 5.4.3.8 End User
    • 5.4.3.9 Functionality
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 Deployment
    • 5.4.4.8 End User
    • 5.4.4.9 Functionality
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 Deployment
    • 5.4.5.8 End User
    • 5.4.5.9 Functionality
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 Deployment
    • 5.4.6.8 End User
    • 5.4.6.9 Functionality
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 Deployment
    • 5.4.7.8 End User
    • 5.4.7.9 Functionality
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 Deployment
    • 5.5.1.8 End User
    • 5.5.1.9 Functionality
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 Deployment
    • 5.5.2.8 End User
    • 5.5.2.9 Functionality
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 Deployment
    • 5.5.3.8 End User
    • 5.5.3.9 Functionality
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 Deployment
    • 5.5.4.8 End User
    • 5.5.4.9 Functionality
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 Deployment
    • 5.5.5.8 End User
    • 5.5.5.9 Functionality
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 Deployment
    • 5.5.6.8 End User
    • 5.5.6.9 Functionality
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 Deployment
    • 5.6.1.8 End User
    • 5.6.1.9 Functionality
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 Deployment
    • 5.6.2.8 End User
    • 5.6.2.9 Functionality
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 Deployment
    • 5.6.3.8 End User
    • 5.6.3.9 Functionality
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 Deployment
    • 5.6.4.8 End User
    • 5.6.4.9 Functionality
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 Deployment
    • 5.6.5.8 End User
    • 5.6.5.9 Functionality

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 3M
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Johnson and Johnson
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Becton Dickinson and Company
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Stryker Corporation
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Medtronic
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Getinge Group
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Steris Corporation
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Cantel Medical
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Ecolab
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Kimberly-Clark
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Halyard Health
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Ansell Limited
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Belimed AG
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Matachana Group
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Advanced Sterilization Products
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Tuttnauer
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Steelco
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Miele Professional
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Olympus Corporation
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Cardinal Health
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us